Radiosurgery aims at the precise destruction of small, defined volumes
of tissue by employing ionizing radiation energy. Its methodologies m
ay be subdivided into closed-skull, external focussed beam radiosurger
y, and interstitial radiosurgery (brachytherapy). Focussed beam stereo
tactic radiosurgery has been used successfully for over two decades to
treat cerebral arteriovenous malformations. Complete obliteration ran
ges from 30 % to 50 % after one year. After two years, obliteration is
observed in up to 90 % of patients. Outcome, however, is influenced b
y patient selection. In the treatment of acoustic neurinomas, follow-u
p data of larger series show that radiosurgery performed under local a
nesthesia on an out-patient basis is competitive with microsurgery dat
a. Using multiple isocenters and magnetic resonance localization, tumo
r growth control is achieved in more than 90 % of patients with preser
vation of hearing in approximately 50 %. Pituitary tumors with Cushing
's syndrome, acromegaly, Nelson's syndrome, prolactinomas and non-secr
eting adenomas have been treated. Only a small subgroup of patients wi
th low-grade gliomas are candidates for interstitial radiosurgery, nam
ely those with circumscribed tumors with limited spread of tumor cells
into the periphery. For this subgroup, which usually comprises not mo
re than 25 % of all low-grade gliomas, interstitial radiosurgery compe
tes with surgical resection. Local, single high-dose treatment remains
controversial for highly malignant infiltrative tumors, and a signifi
cant treatment benefit remains to be demonstrated. Radiosurgery can be
used to effectively treat solitary brain metastases (less than or equ
al to 3 cm diameters) with less invasiveness, and dissection of normal
tissue; it may be performed with lower morbidity and with less expens
e in comparison with open surgery.